Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,222
Closed -$341K 564
2021
Q1
$341K Sell
1,222
-5
-0.4% -$1.35K 0.04% 371
2020
Q4
$301K Buy
+1,227
New +$317K 0.04% 371
2018
Q1
Sell
-4,182
Closed -$1.33M 407
2017
Q4
$1.33M Buy
+4,182
New +$1.34M 0.3% 96
2017
Q3
Sell
-4,067
Closed -$1.1M 280
2017
Q2
$1.1M Hold
4,067
0.32% 96
2017
Q1
$1.11M Sell
4,067
-2
-0% -$565 0.33% 96
2016
Q4
$1.15M Buy
4,069
+40
+1% +$11.9K 0.36% 86
2016
Q3
$1.26M Hold
4,029
0.4% 79
2016
Q2
$974K Sell
4,029
-4
-0.1% -$1.05K 0.31% 107
2016
Q1
$1.05M Sell
4,033
-79
-2% -$20.9K 0.33% 100
2015
Q4
$1.26M Buy
4,112
+74
+2% +$21.3K 0.37% 91
2015
Q3
$1.18M Buy
4,038
+25
+0.6% +$8.26K 0.34% 93
2015
Q2
$1.62M Sell
4,013
-33
-0.8% -$13.2K 0.44% 75
2015
Q1
$1.71M Buy
+4,046
New +$1.59M 0.44% 75
2014
Q3
Sell
-1,017
Closed -$321K 201
2014
Q2
$321K Sell
1,017
-11
-1% -$3.31K 0.15% 163
2014
Q1
$314K Sell
1,028
-24
-2% -$7.62K 0.16% 156
2013
Q4
$294K Sell
1,052
-33
-3% -$8.54K 0.15% 167
2013
Q3
$261K Sell
1,085
-127
-10% -$28.4K 0.15% 159
2013
Q2
$261K Buy
+1,212
New +$259K 0.18% 134

Other funds holding BIIB

Hilltop Holdings's BIIB Position: Q2 2021 in Review

Hilltop Holdings sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,222 shares — an estimated $341K sold.

Hilltop Holdings first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.71M in Q1 2015. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Hilltop Holdings reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Hilltop Holdings sold 1,222 Biogen shares in Q2 2021, an estimated $341K.
  • Hilltop Holdings first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
  • Hilltop Holdings's Biogen position peaked at $1.71M in Q1 2015.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Hilltop Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.